04-29-2020, 09:09 AM
I think they are expecting 400 total patients, not in each arm. Looks like aiming to enroll 286 in each arm to end up with 200 in each reaching end point.
If there is a benefit, it probably won't be a very big one based on the prior study. Also if it was a big benefit, they likely would have stopped trial early.
If there is a benefit, it probably won't be a very big one based on the prior study. Also if it was a big benefit, they likely would have stopped trial early.
